semaglutide shut down FDA is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified What Happens After Stopping Semaglutide?
Description
The National Institute for Health and Care Excellence (NICE) has confirmed draft guidance recommending the use of semaglutide, an appetite suppressant, for overweight and obese adults in the UK

*Obesity GLP-1 Ozempic and Mounjaro Source: IQVIA Analysis

Losing weight is challenging but achievable

Maintain muscle mass while losing fat
